glp 1 semaglutide or tirzepatide & are transforming diabetes & obesity management. These GLP-1 receptor agonists offer benefits from glycemic control to weight loss and cardiovascular risk reduction, emphasizing their broad impact. Read more from Troubling Findings in Study of

Experimental in vivo and in vitro studies provide biological plausibility for these associations by showing that MNP exposure may promote oxidative stress, endothelial dysfunction, chronic inflammation, intestinal dysbiosis, altered lipid metabolism, and thromboinflammatory responses, potentially contributing to a pro-atherosclerotic and pro-thrombotic environment

Exploring the role of goal setting in weight loss for adults recently diagnosed with pre-diabetes

Biomarker profiling can help contextualize whether GLP-1 therapy aligns with your metabolic phenotype

The propensity score represents the predicted probability that was assigned to the SGLT2i group compared with the GLP1-RA group

Key Takeaway Traditional bulking typically results in a 1:1 or even 1:2 ratio of muscle to fat gain, meaning for every pound of muscle built, lifters often accumulate one to two pounds of fat